Original ContributionEvaluation of METHOHEXITAL (cas 18652-93-2) as an alternative to propofol in a high volume outpatient pediatric sedation service

Add time:09/25/2019    Source:sciencedirect.com

BackgroundPropofol is a preferred agent for many pediatric sedation providers because of its rapid onset and short duration of action. It allows for quick turn around times and enhanced throughput. Occasionally, intravenous (IV) METHOHEXITAL (cas 18652-93-2) (MHX), an ultra-short acting barbiturate is utilized instead of propofol.

We also recommend Trading Suppliers and Manufacturers of METHOHEXITAL (cas 18652-93-2). Pls Click Website Link as below: cas 18652-93-2 suppliers

Prev:Case ReportPositive pharmacologic provocative testing with METHOHEXITAL (cas 18652-93-2) during cerebral arteriovenous malformation embolization
Next:Comparison of METHOHEXITAL (cas 18652-93-2) and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders)